Vancomycin shortage — AU supply status & alternatives

Vancomycin

ATC J01XA01 · Glycopeptide antibiotic

🇦🇺 AUST R 330502 · Juno Pharmaceuticals Pty Ltd

In shortage · Australia

WHO Essential Medicine

VancocinVancenase

In declared shortage · 🇦🇺 Australia & also short in🇺🇸 US🇨🇦 CA🇧🇪 BE

Critical shortage

Reading today’s signals…

🇦🇺 AUAEMPA$4.01DPMQ A$35.59details →

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

Linezolid

Related option · therapeutic class alternative

◷ Expected back

July 2026

Sponsor est. via TGA

Product attributes reference data we hold

Active ingredient (INN)	Vancomycin
Brand names	Vancocin, Vancenase
ATC level 5	J01XA01
ATC level 4	J01XA
Drug class	Glycopeptide antibiotic
Therapeutic category	Anti-infective
Strength	125mg · 250mg · 500mg · 1g · 5g
Dosage form	powder for infusion · capsule
Route of administration	intravenous · oral
WHO Essential Medicine	Yes (2023)
Controlled substance	No
Marketing-authorisation holders	Juno Pharmaceuticals Pty Ltd, Alphapharm Pty Ltd, Boucher & Muir Pty Ltd, Baxter Healthcare Pty Ltd +8 more
Registrations on file	22
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$4.01

AEMP

Dispensed (DPMQ)

A$35.59

incl. fees

Pack

vancomycin 500 mg injection, 1 vial

powder for infusion

Source: PBSEffective July 2026 · AUD

Other markets

🇺🇸 US

US$1.49

Acquisition

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 2 resolved events

◷

~5 months

Historical pattern from resolved shortage records — not a prediction of this event.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

9 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Chongqing Daxin Pharmaceutical CO LTDXellia Pharmaceuticals LTDXellia Pharmaceuticals ApsHospira INCLek Pharmaceuticals DdZhejiang Medicine CO LTD+3 more

Manufacturing countries: China, Hungary, Denmark, United States, India · Source: FDA List of Drug Master Files

Shortage status by regulator official notices

🇺🇸

United States

FDA MedWatch · 1mo ago

Critical

🇦🇺

Australia

TGA · 3h ago

Critical

🇨🇦

Canada

HC · 2h ago

High

🇧🇪

FAMHP · 4h ago

Medium

🇳🇱

Netherlands

CBG-MEB · 4mo ago

Medium

Recalls official enforcement reports

🇺🇸

Vancomycin Hcl

Fagron Compounding Services · Mar 2026

Class IIdetails ↗

🇺🇸

Vancomycin Hcl

Fresenius Kabi Compounding, LLC · Feb 2026

Class IIdetails ↗

🇺🇸

Vancomycin Hcl

Fresenius Kabi Compounding, LLC · Feb 2026

Class IIdetails ↗

🇺🇸

Vancomycin Hcl

Fresenius Kabi Compounding, LLC · Sept 2024

Class IIdetails ↗

🇺🇸

VANCOMYCIN HYDROCHLORIDE

Amneal Pharmaceuticals of New York, LLC · Mar 2024

Class Idetails ↗

🇺🇸

Vancomycin

SCA Pharmaceuticals, LLC · Nov 2023

Class IIdetails ↗

Verified timeline regulator events

🇦🇺 1 Aug 2026

Shortage resolved

🇦🇺 1 Aug 2026

Shortage resolved

🇨🇦 8 June 2026

high reported

🇧🇪 21 May 2026

medium reported

🇨🇦 4 May 2026

high reported

🇨🇦 20 Apr 2026

high reported

Sources official regulators

🇺🇸

FDA MedWatch

verified 1h ago

verify ↗

🇨🇦

verified 2h ago

verify ↗

🇺🇸

FDA

verified 3h ago

verify ↗

🇦🇺

TGA

verified 3h ago

verify ↗

🇧🇪

FAMHP

verified 4h ago

verify ↗

🇳🇱

CBG-MEB

verified 4mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders22 registrations · 12 MA holders

Product	Strength	Form	Market	MA holder	Status
Juno	1 g	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active
Juno	500 mg	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active
Vancomycin Viatris	500 mg	—	🇦🇺 AU	Alphapharm Pty Ltd	Active
Vancomycin Viatris	1000 mg	—	🇦🇺 AU	Alphapharm Pty Ltd	Active
Bnm	125 mg	—	🇦🇺 AU	Boucher & Muir Pty Ltd	Active
Bnm	250 mg	—	🇦🇺 AU	Boucher & Muir Pty Ltd	Active
Baxter	1 g	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
Baxter	500 mg	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
VANCOMYCIN 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION	500 MG	solution	🇬🇧 GB	HAMELN PHARMA LTD	Active
VANCOMYCIN 1000 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION	1000 MG	solution	🇬🇧 GB	HAMELN PHARMA LTD	Active
VANCOMYCIN 125MG HARD CAPSULES	125MG	capsule	🇬🇧 GB	STRIDES PHARMA UK LIMITED	Active
VANCOMYCIN 250 MG HARD CAPSULES	250 MG	capsule	🇬🇧 GB	STRIDES PHARMA UK LIMITED	Active
VANCOMYCIN, 500 MG, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION	500 MG	solution	🇬🇧 GB	HIKMA FARMACEUTICA (PORTUGAL) SA	Active
VANCOMYCIN, 1000 MG, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION	1000 MG	solution	🇬🇧 GB	HIKMA FARMACEUTICA (PORTUGAL) SA	Active
VANCOMYCIN 500 MG POWDER FOR SOLUTION FOR INFUSION	500 MG	solution	🇬🇧 GB	ZENTIVA PHARMA UK LIMITED	Active

+7 more registrations on file

Mederti Drug Report

Generated 1 July 2026 · Australia market · 6 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.